Human Molecular Genetics, 2002, Vol. 11, No. 17 2037-2049
© 2002 Oxford University Press
hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-ß1
Institute of Human Genetics, University of Bonn, Bonn, Germany
Received May 7, 2002; Accepted June 18, 2002
Proximal spinal muscular atrophy (SMA) is a common motor neuron disease caused by homozygous loss of the survival motor neuron gene (SMN1). SMN2, a nearly identical copy of the gene and present in all SMA patients, fails to provide protection from SMA, due to the disruption of an exonic splicing enhancer (ESE) by a single translationally silent nucleotide exchange, which causes alternative splicing of SMN2 exon 7. Identification of splicing factors that stimulate exon 7 inclusion and thereby produce sufficient amounts of full-length transcripts from the SMN2 gene is of great importance for therapy approaches. Here, by use of in vivo splicing assays, we identified the protein hnRNP-G and its paralogue RBM as two novel splicing factors that promote the inclusion of SMN2 exon 7. Moreover, hnRNP-G and RBM non-specifically bind RNA, but directly and specifically bind Htra2-ß1, an SR-like splicing factor which we have previously shown to stimulate inclusion of exon 7 through a direct interaction with the AG-rich ESE in SMN2 exon 7 pre-mRNA. By using deletion mutants of hnRNP-G, we show that the specific protein–protein interaction of hnRNP-G with Htra2-ß1 mediates the inclusion of SMN2 exon 7 rather than the non-specific interaction of hnRNP-G with SMN pre-mRNA. Additionally, we show for the first time that recombinant trans-acting splicing factors such as hnRNP-G and Htra2-ß1 are also effective on endogenous SMN2 transcripts and increase the endogenous SMN protein level. Finally, we suggest a model of how the exon 7 mRNA processing is regulated by the splicing factors identified so far.
* To whom correspondence should be addressed at: University of Bonn, Institute of Human Genetics, Wilhelmstr. 31, 53111 Bonn, Germany. Tel: +49 2282872344; Fax: +49 2282872380; Email: bwirth{at}uni-bonn.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. L. Hastings, J. Berniac, Y. H. Liu, P. Abato, F. M. Jodelka, L. Barthel, S. Kumar, C. Dudley, M. Nelson, K. Larson, et al. Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy Science Translational Medicine, November 4, 2009; 1(5): 5ra12 - 5ra12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Garbes, M. Riessland, I. Holker, R. Heller, J. Hauke, C. Trankle, R. Coras, I. Blumcke, E. Hahnen, and B. Wirth LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate Hum. Mol. Genet., October 1, 2009; 18(19): 3645 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Heinrich, Z. Zhang, O. Raitskin, M. Hiller, N. Benderska, A. M. Hartmann, L. Bracco, D. Elliott, S. Ben-Ari, H. Soreq, et al. Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA J. Biol. Chem., May 22, 2009; 284(21): 14303 - 14315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Baughan, A. Dickson, E. Y. Osman, and C. L. Lorson Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy Hum. Mol. Genet., May 1, 2009; 18(9): 1600 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Martins de Araujo, S. Bonnal, M. L. Hastings, A. R. Krainer, and J. Valcarcel Differential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP RNA, April 1, 2009; 15(4): 515 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Chen, J.-G. Chang, R.-M. Lu, T.-Y. Peng, and W.-Y. Tarn The RNA Binding Protein hnRNP Q Modulates the Utilization of Exon 7 in the Survival Motor Neuron 2 (SMN2) Gene Mol. Cell. Biol., November 15, 2008; 28(22): 6929 - 6938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Bose, I.-F. Wang, L. Hung, W.-Y. Tarn, and C.-K. J. Shen TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing J. Biol. Chem., October 24, 2008; 283(43): 28852 - 28859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cloutier, J. Toutant, L. Shkreta, S. Goekjian, T. Revil, and B. Chabot Antagonistic Effects of the SRp30c Protein and Cryptic 5 ' Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x J. Biol. Chem., August 1, 2008; 283(31): 21315 - 21324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Sumner Molecular Mechanisms of Spinal Muscular Atrophy J Child Neurol, August 1, 2007; 22(8): 979 - 989. [Abstract] [PDF]
|
|
|
|
 |
|
 N. N. Singh, R. N. Singh, and E. J. Androphy Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes Nucleic Acids Res., January 28, 2007; 35(2): 371 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Qi, S. Su, M. E. McGuffin, and W. Mattox Concentration dependent selection of targets by an SR splicing regulator results in tissue-specific RNA processing Nucleic Acids Res., December 4, 2006; 34(21): 6256 - 6263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Watermann, Y. Tang, A. zur Hausen, M. Jager, S. Stamm, and E. Stickeler Splicing Factor Tra2-{beta}1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene. Cancer Res., May 1, 2006; 66(9): 4774 - 4780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Disset, C.F. Bourgeois, N. Benmalek, M. Claustres, J. Stevenin, and S. Tuffery-Giraud An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements Hum. Mol. Genet., March 15, 2006; 15(6): 999 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Singh, N. N. Singh, E. J. Androphy, and R. N. Singh Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron Mol. Cell. Biol., February 15, 2006; 26(4): 1333 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D'Souza and G. D. Schellenberg Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer: ALTERED INTERACTIONS AND MECHANISMS FOR FUNCTIONALLY ANTAGONISTIC FTDP-17 MUTATIONS {Delta}280K AND N279K J. Biol. Chem., February 3, 2006; 281(5): 2460 - 2469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Park, J. Han, G. H. Son, M. S. Lee, S. Chung, S. H. Park, K. Park, K. H. Lee, S. Choi, J. Y. Seong, et al. Cooperative Actions of Tra2{alpha} with 9G8 and SRp30c in the RNA Splicing of the Gonadotropin-releasing Hormone Gene Transcript J. Biol. Chem., January 6, 2006; 281(1): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grondard, O. Biondi, A.-S. Armand, S. Lecolle, B. D. Gaspera, C. Pariset, H. Li, C.-L. Gallien, P.-P. Vidal, C. Chanoine, et al. Regular Exercise Prolongs Survival in a Type 2 Spinal Muscular Atrophy Model Mouse J. Neurosci., August 17, 2005; 25(33): 7615 - 7622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Venables, C. F. Bourgeois, C. Dalgliesh, L. Kister, J. Stevenin, and D. J. Elliott Up-regulation of the ubiquitous alternative splicing factor Tra2{beta} causes inclusion of a germ cell-specific exon Hum. Mol. Genet., August 15, 2005; 14(16): 2289 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jarecki, X. Chen, A. Bernardino, D. D. Coovert, M. Whitney, A. Burghes, J. Stack, and B. A. Pollok Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy Hum. Mol. Genet., July 15, 2005; 14(14): 2003 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Hsu, P.-L. Shao, K.-L. Tsai, H.-C. Shih, T.-Y. Lee, and C. Hsu Gene regulation by NMDA receptor activation in the SDN-POA neurons of male rats during sexual development J. Mol. Endocrinol., April 1, 2005; 34(2): 433 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. SINGH, E. J. ANDROPHY, and R. N. SINGH In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes RNA, August 1, 2004; 10(8): 1291 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Brichta, Y. Hofmann, E. Hahnen, F. A. Siebzehnrubl, H. Raschke, I. Blumcke, I. Y. Eyupoglu, and B. Wirth Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy Hum. Mol. Genet., October 1, 2003; 12(19): 2481 - 2489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Nasim, T. K. Chernova, H. M. Chowdhury, B.-G. Yue, and I. C. Eperon HnRNP G and Tra2{beta}: opposite effects on splicing matched by antagonism in RNA binding Hum. Mol. Genet., June 1, 2003; 12(11): 1337 - 1348. [Abstract] [Full Text] [PDF]
|
|